BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Buyse M. Contributions of meta-analyses based on individual patient data to therapeutic progress in colorectal cancer. Int J Clin Oncol 2009;14:95-101. [PMID: 19390939 DOI: 10.1007/s10147-009-0879-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Sargent DJ, Buyse M, Matheson A, Goldberg RM, de Gramont A; ARCAD Clinical Trials Program. The ARCAD clinical trials program: an update and invitation. Oncologist 2012;17:188-91. [PMID: 22302228 DOI: 10.1634/theoncologist.2011-0332] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
2 Michiels S, Saad ED, Buyse M. Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid Tumors. Drugs 2017;77:713-9. [DOI: 10.1007/s40265-017-0728-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
3 Buyse M. Use of meta-analysis for the validation of surrogate endpoints and biomarkers in cancer trials. Cancer J 2009;15:421-5. [PMID: 19826362 DOI: 10.1097/PPO.0b013e3181b9c602] [Cited by in Crossref: 26] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
4 Sherrill B, Kaye JA, Sandin R, Cappelleri JC, Chen C. Review of meta-analyses evaluating surrogate endpoints for overall survival in oncology. Onco Targets Ther 2012;5:287-96. [PMID: 23109809 DOI: 10.2147/OTT.S36683] [Cited by in Crossref: 33] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
5 Pigott T, Williams R, Polanin J. Combining individual participant and aggregated data in a meta-analysis with correlational studies. Res Synth Methods 2012;3:257-68. [PMID: 26053420 DOI: 10.1002/jrsm.1051] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
6 Kawahara T, Fukuda M, Oba K, Sakamoto J, Buyse M. Meta-analysis of randomized clinical trials in the era of individual patient data sharing. Int J Clin Oncol 2018;23:403-9. [PMID: 29330642 DOI: 10.1007/s10147-018-1237-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
7 Buyse M, Sargent DJ, Grothey A, Matheson A, de Gramont A. Biomarkers and surrogate end points--the challenge of statistical validation. Nat Rev Clin Oncol. 2010;7:309-317. [PMID: 20368727 DOI: 10.1038/nrclinonc.2010.43] [Cited by in Crossref: 212] [Cited by in F6Publishing: 172] [Article Influence: 17.7] [Reference Citation Analysis]